Volume 2, Problème 1 (2005)
Article de révision
The anandamide membrane transporter and the therapeutic implications of its inhibition
Natalia Battista, Valeria Gasperi, Filomena Fezza and Mauro Maccarrone
Article de révision
Stromal cells as new therapeutic targets in rheumatoid arthritis
Oliver Haworth, Angela Burman, Greg Parsonage, Andrew Filer, Mike Salmon and Christopher D Buckley
Article de révision
An overview of the beneficial cardiovascular effects of thiazolidinediones
Fadi A El-Atat, John Nicasio, Luther T Clark and Samy I McFarlane
article de recherche
Short-term effect of sibutramine versus placebo on mood in depressed and non-depressed obese patients
Kristina Elfhag and Stephan Rossner
article de recherche
Two-hour post dose cyclosporine monitoring does not fit all in kidney transplantation
Dario Cattaneo, Flavio Gaspari, Stefania Zenoni, Sara Baldelli, Eliana Gotti, Annalisa Perna, Norberto Perico and Giuseppe Remuzzi
article de recherche
Experience with refractory vitamin D resistant rickets and non-17 alkyl testosterone derivative anabolic agent
Aamir Jalal Al-Mosawi
article de recherche
Purine and nonpurine pharmacological CDK inhibitors target initiation of viral transcription
Jonathan J Lacasse, Veronic MI Provencher, Matthew D Urbanowski and Luis M Schang
Cour de rapport
The mutant prevention concentration as a strategy to minimize antimicrobial resistance- a timely concept but will it\'s acceptance be too late?
Glen T Hansen and Joseph M Blondeau
Cour de rapport
The changing role of thrombolytic therapy in the management of acute deep vein thrombosis
Mahmood K Razavi and Charles P Semba
Évaluation des médicaments
Pimecrolimus for the treatment of atopic dermatitis
Kristine Breuer, Thomas T Werfel & Alexander Kapp
Évaluation des médicaments
Adalimumab for the treatment of rheumatoid arthritis
Susan J Lee and Arthur Kavanaugh
Évaluation des médicaments
Orlistat- An update after the first half decade of clinical experience
Liam J Murphy
